Anúncios
relacionados a: esquemic colorectal cancer and brain metastasis pdfCancer Research Institute needs your help fighting cancer. Donate today. Discover game-changing treatment options for brain cancer with immunotherapy.
- Ways to Give Back
Donate, fundraise, shop, or match.
Make a charitable bequest, registry
- Why Donate?
We can change the way cancer is
treated and cured. Make an impact.
- Ways to Give Back
Learn More About Brain Tumor Treatment Options. Get Access to Our Free Treatment Guide. Cleveland Clinic's Brain Tumor Program Has Experts to Treat Your Condition. Call Now.
Resultado da Busca
21 de fev. de 2021 · Abstract. Colorectal cancer (CRC) is the third most common malignancy worldwide. Most patients with metastatic CRC develop liver or lung metastases, while a minority suffer from brain metastases. There is little information available regarding the presentation, treatment, and overall survival of brain metastases (BM) from CRC.
Brain metastases (BM) from colorectal cancer (CRC) are a rare event. However, the implications for affected patients are severe, and the incidence has been reported to be increasing. For clinicians, knowledge about the characteristics associated with BM is important and could lead to earlier diagnosis and improved survival. Method:
- Troels Dreier Christensen, Karen-Lise Garm Spindler, Jesper Andreas Palshof, Dorte Lisbet Nielsen
- 2016
22 de jan. de 2021 · Conclusions: Brain metastases are rare in colorectal cancer but portend poor survival. Lung and bone metastases are found more frequently in these patients. Treatment with metastasectomy or multiagent chemotherapy is associated with improved overall survival.
- Suleyman Yasin Goksu, Muhammad Shaalan Beg, Aravind Sanjeevaiah, Emrah Gumusgoz, David Hsieh, Muhamm...
- 2021
21 de fev. de 2021 · Brain Metastases from Colorectal Cancer: A Systematic Review of the Literature and Meta-Analysis to Establish a Guideline for Daily Treatment. February 2021. Cancers 13 (4):900. DOI:...
Brain metastasis (BM) in colorectal cancer patients is rare and is associated with dismal outcomes. Our study aims to evaluate the incidence and predictors of BM in patients with colorectal cancer. Methods. We performed a retrospective analysis (2010–2017) of patients with a primary diagnosis of colorectal cancer (CRC).
4 de fev. de 2020 · Background: More than 50% of colorectal cancer (CRC) patients will develop metastatic disease. Brain metastasis (BM) from colorectal cancer is uncommon (0.6-1.36%). This study aims to investigate the patient characteristics, treatment modalities and prognostic factors in this rare population.
Anúncio
relacionado a: esquemic colorectal cancer and brain metastasis pdfRead About the Benefits & Risks Of A Treatment Option, Access Patient Resources & Support. A Treatment Option For HER2+ Metastatic Breast Cancer. Downloads FAQs.
